Drug Profile
Estradiol/etonogestrel intravaginal ring - Merck
Alternative Names: ENG-CVR; ENG-E2; ENG/CVR; Etonogestrel/17β-estradiol; Etonogestrel/estradiol intravaginal ring; MK-8342B; SCH 900432Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dysmenorrhoea; Pregnancy
Most Recent Events
- 28 Feb 2017 Discontinued - Phase-II for Dysmenorrhoea in Germany, Netherlands, Spain, Denmark, Norway (Vaginal) due to business reasons (Merck Annual report 2016)
- 28 Feb 2017 Discontinued - Phase-III for Dysmenorrhoea in Finland, USA, Sweden, Poland (Vaginal) due to business reasons (Merck Annual report 2016)
- 28 Feb 2017 Discontinued - Phase-III for Pregnancy (Prevention) in USA, Puerto Rico, Norway, Finland, Netherlands, Germany, Spain, Hungary, Poland, Sweden, Austria, Denmark, Czech Republic (Vaginal) due to business reasons (Merck Annual report 2016)